Imiquimod-induced bullous pemphigoid: A case report
- PMID: 37025248
- PMCID: PMC10071145
- DOI: 10.1177/2050313X231164222
Imiquimod-induced bullous pemphigoid: A case report
Abstract
A 72-year-old man treated with 3.5% imiquimod cream for scalp actinic keratoses developed the usual crusted and erosive reaction but developed bullae on the scalp, as well as the limbs and torso after several weeks into treatment. Biopsy confirmed bullous pemphigoid. He was treated with clobetasol ointment, prednisone and methotrexate, with eventual disease control. He had a severe disease course. Bullous pemphigoid is usually idiopathic, but can be induced by skin trauma, as well as by several medications; this is the first report of imiquimod as a trigger. Imiquimod is a toll-like receptor 7 agonist that induces cellular apoptosis and recruits pro-inflammatory cytokines including tumour necrosis factor-alpha and interferon-alpha, which have been implicated in autoimmunity. This case highlights an unusual but severe adverse effect from topical imiquimod.
Keywords: Bullous pemphigoid; actinic keratoses; imiquimod.
© The Author(s) 2023.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Mashiah J, Brenner S. Possible mechanisms in the induction of pemphigus foliaceus by topical imiquimod treatment. Arch Dermatol 2005; 141(7): 908–909. - PubMed
-
- Feng S, Zhou W, Zhang J, et al.. Analysis of 6 cases of drug-induced pemphigus. Eur J Dermatol 2011; 21(5): 696–699. - PubMed
-
- Fleischmann M, Celerier P, Bernard P, et al.. Long-term interferon-alpha therapy induces autoantibodies against epidermis. Dermatology 1996; 192(1): 50–55. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
